Allermi

Personalized allergy care, delivered.

San Francisco, United States · Founded 2020 · $4.8M raised

Employees
11–50
Founded
2020
Business Model
B2C
Total Funding
$4.8M
Last Round
$3.5M SeedMar 2023
Rounds
2

About

Allermi is a telehealth company offering personalized prescription allergy nasal sprays compounded by pharmacists based on each patient's specific allergy profile. Founded by Stanford-trained allergists, Allermi replaces generic OTC allergy medications with evidence-based, custom-formulated sprays delivered directly to patients. The platform combines an online allergy assessment, physician review, and subscription-based delivery of custom treatments.

Summary

Allermi is a Healthcare company based in San Francisco, United States, founded in 2020. It has raised $4.8M in total across 2 rounds, most recently a $3.5M Seed round in Mar 2023. Investors include Nelstone Ventures and Lucas Venture Group.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

SeedSeed RoundMar 2023
$3.5M

Sign up to see all 2 rounds

Pre-Seed through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allermi on Indexed.vc
<a href="https://indexed.vc/companies/allermi"><img src="https://indexed.vc/api/badge/company/allermi" alt="Allermi on Indexed.vc" width="260" height="76" /></a>